Here we present a comprehensive magnetic characterization of synthesized non-ideal single-domain (SD) monoclinic pyrrhotite (Fe 7 S 8). The samples were in the form of a powder and a powder dispersed in epoxy. ''Non-ideal" refers to a powder fraction of predominantly SD size with a minor contribution of small pseudo-single-domain grains; such non-ideal SD pyrrhotite was found to be a remanence carrier in several types of meteorites (carbonaceous chondrites, SNC.. .), which justifies the usage of synthetic compositions as analogous to natural samples. Data were collected from 5 to 633 K and include low-field magnetic susceptibility (v 0), thermomagnetic curves, major hysteresis loops, backfield remanence demagnetization curves, first-order reversal curves (FORCs), alternating field and pressure demagnetization of saturation isothermal remanent magnetization (SIRM), low temperature data (such as zero-field-cooled and field-cooled remanence datasets together with room temperature SIRM cooling-warming cycles) as well as XRD and Mössbauer spectra. The characteristic Besnus transition is observed at $33 K. FORC diagrams indicate interacting SD grains. The application of hydrostatic pressure up to 2 GPa using nonmagnetic high-pressure cells resulted in the demagnetization of the sample by 32-38%. Repeated cycling from 1.8 GPa to atmospheric pressure and back resulted in a total remanence decrease of 44% (after 3 cycles). Pressure demagnetization experiments have important implications for meteorite paleomagnetism and suggest that some published paleointensities of meteorites with non-ideal SD monoclinic pyrrhotite as remanence carrier may be lower limits because shock demagnetization was not accounted for.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.